Rate of development low in pharma?
In the biopharmaceutical industry, the rate of development is low. There is, thus, little fear that a patented invention will be replaced before the patent's statutory life expires.
What can one say?
Elsewhere, the goal of the incentives patent law is attempting to create -- to encourage inventions of patentable quality.